EmpowerPharm Inc. (“EmpowerPharm” or “the Company”) is a Canadian pharmaceutical company dedicated to developing pharmaceutical grade cannabidiol (CBD)† therapies in solid oral dose formats. Its

In the evolving landscape of neurological disorders, epilepsy stands out as a complex challenge that affects millions of adults worldwide. The quest for more effective treatments has led us to innovate and explore groundbreaking methodologies in drug delivery systems. At the forefront of our research is the expanded application of our advanced Super Self-Nanoemulsifying Drug Delivery System (Super SNEDDS) technology.

EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD). The results demonstrated efficacy for a subset of patients suffering from moderate to severe SAD.

Burlington, ON March 11, 2024 – EmpowerPharm Inc. is delighted to announce that the final participant has completed their treatment in the Phase II clinical trial assessing the efficacy of pharmaceutical-grade Cannabidiol (CBD) for Social Anxiety Disorder. The anticipated release of the top-line results are due next month in April.

EmpowerPharm® a clinical stage pharmaceutical company specializing in cannabinoid-based drug development of prescription products. These products target therapeutic indications where patients need safe and efficacious

EmpowerPharm Inc., a clinical-stage pharmaceutical company dedicated to research and clinical advancement, disclosed today that the last participant concluded the treatment and active involvement

This was a virtual panel discussion between leading clinical experts on the state of anxiety in Canada discussing existing and emerging treatments and trends. The

EmpowerPharm Inc was pleased to be invited to participate as a featured guest on the Advancements with Ted Danson series, broadcasted throughout North America.

EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been dosed in their Company-sponsored Phase II clinical study.

EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been enrolled in their Company-sponsored Phase II clinical study.